Complement-mediated Disease
Complement-Med Disease is a pathological condition in which dysregulation or overactivation of the complement system directly contributes to tissue damage, inflammation, or immune dysfunction, distinguishing it from other immune-mediated disorders by its specific dependence on complement pathway effector mechanisms.
523
Publications
33.1K
Citations
2.9K
Authors
923
Institutions
Publications per year
2017–2026
114
Parents
523
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text
Marina Noris, Jessica Caprioli, Elena Bresin et al. · Clinical Journal of the American Society of Nephrology · 2010 · 1K citations · Full text
1–5 of 523
2.9K
15
h-index
10
h-index
10
h-index
Centro de Investigaciones Biológicas Margarita Salas, Spain
8 publications · 1.4K citations
8
h-index
8
h-index
1–5 of 2.9K
923
Assistance Publique – Hôpitaux de Paris
Paris, France
17 h-index
55 publications
6.7K citations
Inserm
Paris, France
17 h-index
65 publications
10.1K citations
Hôpital Européen
Marseille, France
15 h-index
44 publications
13.5K citations
Université Paris Cité
Paris, France
15 h-index
45 publications
6.3K citations
Hôpital Européen Georges-Pompidou
Paris, France
14 h-index
41 publications
12.6K citations

Imperial College London
London, United Kingdom
13 h-index
48 publications
7.1K citations
University College London
London, United Kingdom
13 h-index
39 publications
2.4K citations
Mayo Clinic
Rochester, United States
12 h-index
43 publications
5.3K citations
1–8 of 923
Repository · 54 publications · 2.1K citations
22
h-index
14 publications · 1.5K citations
13
h-index
14 publications · 588 citations
13
h-index
11 publications · 265 citations
11
h-index
JI · 11 publications · 774 citations
11
h-index
1–5